This excerpt taken from the EBS 8-K filed Jan 28, 2009.
5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
On January 22, 2009, Robert G. Kramer, a named executive officer of Emergent BioSolutions Inc., resigned his position as head of the Emergent's manufacturing subsidiary. On January 26, 2009, Mr. Kramer assumed new responsibilities as program lead for Emergents recombinant anthrax vaccine (rPA) program. In this capacity, and in the event Emergent receives an rPA contract from the U.S. Department of Health and Human Services, Mr. Kramer will manage all aspects of the project and contract, including the development, manufacture and delivery of Emergent's rPA vaccine into the U.S. strategic national stockpile. Following his role in managing the activities leading up to and under the potential rPA contract award, Mr. Kramer intends to retire.